Dupilumab Asthma ADVANTAGE-EU: Real-World Evidence on the Association Between Dupilumab and Use of Corticosteroid and Asthma Exacerbations in Patients With Severe Asthma in Europe

被引：0
|
作者：
Bourdin, A. [1 ]
Canonica, G. [2 ]
Virchow, J. [3 ,4 ]
Jacob-Nara, J. [5 ]
Borsos, K. [5 ]
Stanford, R. H. [6 ]
Pandit-Abid, N. [5 ]
Wang, Z. [7 ]
Soler, X. [7 ]
Huynh, L. [8 ]
Kalia, S. [8 ]
Duh, M. [8 ]
Cheng, W. [5 ]
机构：
[1] Univ Montpellier, CHU Montpellier, Dept Resp Dis, Montpellier, France
[2] IRCCS, Humanitas Clin & Res Ctr, Personalized Med Asthma & Allergy, Milan, Italy
[3] Univ Med, Dept Pneumol, Rostock, Germany
[4] Univ Med, Intens Care Med, Rostock, Germany
[5] Sanofi, Cambridge, MA USA
[6] AESARA Inc, Chapel Hill, NC USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Anal Grp Inc, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6698
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Baseline Characteristics Of Patients With Asthma Treated With Dupilumab In A Real-World Setting: The RAPID Registry
    Lugogo, Njira
    Soler, Xavier
    Menzies-Gow, Andrew
    Peters, Anju
    Cote, Andreanne
    Hilberg, Ole
    Xia, Changming
    Zhang, Yi
    Gomez, Lucia De Prado
    Rowe, Paul
    Radwan, Amr
    Jacob-Nara, Juby
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB21 - AB21
  • [32] The RAPID Registry: A Global Real-World Cohort of Patients Receiving Dupilumab for the Treatment of Moderate-to-Severe Asthma
    Jain, N.
    Soong, W.
    Settipane, R. A.
    Gall, R.
    Zhen, C.
    Zhang, Y.
    Tmirah, H.
    Jacob-Nara, J. A.
    Ortiz, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] Dupilumab responder types and predicting factors in patients with type 2 severe asthma: A real-world cohort study
    Bult, L.
    Thelen, J. C.
    Rauh, S. P.
    in't Veen, J. C. C. M.
    Braunstahl, G. J.
    RESPIRATORY MEDICINE, 2024, 231
  • [34] Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world observational study
    Bult, Lotte
    Thelen, J. C.
    In't Veen, J. C. C. M.
    Braunstahl, G. J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study
    Thelen, John C.
    van Zelst, Cathelijne M.
    van Brummelen, Sigrid E.
    Rauh, Simone
    Kappen, Jasper H.
    in't Veen, Johannes C. C. M.
    Kappen, Jasper H.
    Braunstahl, Gert-Jan
    RESPIRATORY MEDICINE, 2023, 206
  • [36] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [37] DUPILUMAB REDUCES SEVERE OUTPATIENT ASTHMA EXACERBATIONS, CUMULATIVE DOSE, AND TOTAL NUMBER OF DAYS OF SYSTEMIC CORTICOSTEROID USE AMONG PATIENTS WITH MODERATE-TO-SEVERE TYPE-2 ASTHMA
    Canonica, Giorgio Walter
    Zeiger, Robert
    Castro, Mario
    Msihid, Jerome
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Kamat, Siddhesh
    Khan, Asif
    CHEST, 2020, 158 (04) : 1810A - 1812A
  • [38] DUPILUMAB REDUCED EXACERBATIONS AND IMPROVED LUNG FUNCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA AND PRIOR EXACERBATIONS: LIBERTY ASTHMA TRAVERSE STUDY
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    CHEST, 2022, 162 (04) : 1936A - 1938A
  • [39] DUPILUMAB REDUCES SEVERE EXACERBATIONS IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA WITH AND WITHOUT EARLY IMPROVEMENTS IN LUNG FUNCTION
    Hanania, Nicola
    Castro, Mario
    Mirapeix, Christian
    Bateman, Eric
    Rice, Megan
    Djandji, Michel
    Ballard, Mark
    Rowe, Paul
    Deniz, Yamo
    Teper, Ariel
    CHEST, 2019, 156 (04) : 929A - 932A
  • [40] Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study
    Fukunaga, Koichi
    Tagaya, Etsuko
    Ishida, Masato
    Sunaga, Yoshinori
    Koshiba, Ryuji
    Yokoyama, Akihito
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (04) : 537 - 544
12345